BAM
MESO

Belpointe Asset Management’s Mesoblast MESO Stock Holding History

Belpointe Asset Management’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,060
Closed -$13.6K – 2214
2023
Q1 		$13.6K Hold
2,060
– – ﹤0.01% 2541
2022
Q4 		$12K Buy
+2,060
New +$12.9K ﹤0.01% 2518

Other funds holding MESO

PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
LCM
Lazari Capital Management Woodland Hills, California $287M AUM 28.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Belpointe Asset Management's MESO Position: Q2 2023 in Review

Belpointe Asset Management sold out of Mesoblast (MESO) in Q2 2023, closing a stake of 2,060 shares — an estimated $13.6K sold.

Belpointe Asset Management first reported a position in MESO in Q4 2022 and held it in 2 quarters. The position peaked at $13.6K in Q1 2023. 43 funds tracked by Wall St. Rank hold MESO as of Q2 2023.

  • Belpointe Asset Management reported no remaining Mesoblast position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 2,060 Mesoblast shares in Q2 2023, an estimated $13.6K.
  • Belpointe Asset Management first reported a position in Mesoblast in Q4 2022 and held it in 2 quarters.
  • Belpointe Asset Management's Mesoblast position peaked at $13.6K in Q1 2023.
  • 43 funds tracked by Wall St. Rank held Mesoblast as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.